Update on the Development of Standardized mRNA/LNP CQAs for Therapeutic Applications
Time: 2:30 pm
day: Conference Day Two
Details:
- Current state of existing regulatory guidance
- Review of the proposed list of CQAs, and analytical methods
- Areas for additional development
- CRISPR-specific considerations
